Tech Company Financing Transactions
Recombine Funding Round
FirstMark Capital and private investors participated in a $3.3 million venture round for Recombine. The financing was announced on 3/5/2014.
Transaction Overview
Company Name
Announced On
3/5/2014
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Undisclosed
Investors
FirstMark Capital (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1140 Bdwy. 1100
New York, NY 10001
USA
New York, NY 10001
USA
Phone
Website
Email Address
Not Recorded
Overview
Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine's genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexander Bisignano
Chief Scientific Officer
Santiago Munne
Browse more venture capital transactions:
Prev: 3/5/2014: Reflektion venture capital transaction
Next: 3/5/2014: PetHub venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs